ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 28 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $21,339,000 | -42.6% | 19,250,000 | -51.6% | 0.01% | -41.2% |
| Q2 2019 | $37,146,000 | -6.2% | 39,750,000 | -3.6% | 0.02% | -15.0% |
| Q1 2019 | $39,596,000 | -13.8% | 41,250,000 | -27.9% | 0.02% | -20.0% |
| Q4 2018 | $45,952,000 | +77.9% | 57,250,000 | +138.5% | 0.02% | +108.3% |
| Q3 2018 | $25,836,000 | -8.3% | 24,000,000 | -11.1% | 0.01% | -14.3% |
| Q2 2018 | $28,182,000 | -13.7% | 27,000,000 | -23.9% | 0.01% | -22.2% |
| Q1 2018 | $32,662,000 | – | 35,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 52,517,000 | $50,131,000 | 4.53% |
| Mohican Financial Management, LLC | 1,250,000 | $1,196,000 | 3.90% |
| Redmile Group, LLC | 25,000,000 | $23,865,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,195,000 | $30,920,000 | 0.42% |
| PFM Health Sciences, LP | 17,213,000 | $16,517,000 | 0.36% |
| SSI INVESTMENT MANAGEMENT LLC | 2,750,000 | $2,626,000 | 0.22% |
| Rock Springs Capital Management LP | 5,000,000 | $4,798,000 | 0.18% |
| Partner Investment Management, L.P. | 137,000 | $131,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,000,000 | $3,830,000 | 0.12% |
| DAFNA Capital Management LLC | 250,000 | $240,000 | 0.10% |